RT Journal Article
T1 Rhabdomyolysis in a patient under treatment with sorafenib.
A1 Díaz Alcázar, María Del Mar
A1 Cervilla Sáez de Tejada, Eloísa
A1 Ruiz Escolano, Elena
AB We present a case of rhabdomyolysis related to treatment with sorafenib in a patient with multifocal hepatocellular carcinoma. Rhabdomyolysis is a severe situation and potentially fatal. There are no laboratory data that can predict this condition. Early diagnosis is essential for prognosis. Rhabdomyolysis has been described as an adverse reaction of several drugs but it is not frequently related to sorafenib.
SN 1130-0108
YR 2020
FD 2020
LK http://hdl.handle.net/10668/14977
UL http://hdl.handle.net/10668/14977
LA en
DS RISalud
RD Apr 17, 2025